نتایج جستجو برای: androgen antagonist

تعداد نتایج: 82143  

2013
Eric G. Bluemn Elysia Sophie Spencer Brigham Mecham Ryan R. Gordon Ilsa Coleman Daniel Lewinshtein Elahe Mostaghel Xiaotun Zhang James Annis Carla Grandori Christopher Porter Peter S. Nelson

Metastatic prostate cancers generally rely on androgen receptor (AR) signaling for growth and survival, even following systemic androgen-deprivation therapy (ADT). However, recent evidence suggests that some advanced prostate cancers escape ADT by using signaling programs and growth factors that bypass canonical AR ligandmediated mechanisms.We used an in vitro high-throughput RNA interference (...

2011
Vivek Choudhary Ismail Kaddour-Djebbar Vijayabaskar Lakshmikanthan Taghreed Ghazaly Gagan Singh Thangjam Arun Sreekumar Ronald W. Lewis Ian G. Mills Wendy B. Bollag Vijay Kumar

Androgen and androgen receptors (AR) play critical roles in the proliferation of prostate cancer through transcriptional regulation of target genes. Here, we found that androgens upregulated the expression of dynamin-related protein 1 (Drp1), which is involved in the induction of mitochondrial fission, a common event in mitosis and apoptosis. Clinical tissue samples and various prostate cancer ...

Journal: :Chemistry & biology 2011
Daniel K Nomura Donald P Lombardi Jae Won Chang Sherry Niessen Anna M Ward Jonathan Z Long Heather H Hoover Benjamin F Cravatt

Cancer cells couple heightened lipogenesis with lipolysis to produce fatty acid networks that support malignancy. Monoacylglycerol lipase (MAGL) plays a principal role in this process by converting monoglycerides, including the endocannabinoid 2-arachidonoylglycerol (2-AG), to free fatty acids. Here, we show that MAGL is elevated in androgen-independent versus androgen-dependent human prostate ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2005
Casey E Bohl Wenqing Gao Duane D Miller Charles E Bell James T Dalton

Carcinoma of the prostate is the most commonly diagnosed cancer in men. The current pharmacological treatment of choice for progressive androgen-dependent prostate cancer is the nonsteroidal antiandrogen, bicalutamide, either as monotherapy or with adjuvant castration or luteinizing hormone-releasing hormone superagonists to block the synthesis of endogenous testosterone. To date, no nonsteroid...

2017
Charly Abi Ghanem Cindy Degerny Rashad Hussain Philippe Liere Antoine Pianos Sophie Tourpin René Habert Wendy B Macklin Michael Schumacher Abdel M Ghoumari

The oligodendrocyte density is greater and myelin sheaths are thicker in the adult male mouse brain when compared with females. Here, we show that these sex differences emerge during the first 10 postnatal days, precisely at a stage when a late wave of oligodendrocyte progenitor cells arises and starts differentiating. Androgen levels, analyzed by gas chromatography/tandem-mass spectrometry, we...

Journal: :Cancer research 1994
D Dondi P Limonta R M Moretti M M Marelli E Garattini M Motta

The therapeutic options for the treatment of androgen-independent prostatic cancers are rather limited; this is mainly because our understanding of the local mechanisms involved in the control of androgen-independent proliferation of the tumor is still very poor. The present experiments have been performed to verify whether luteinizing hormone-releasing hormone (LHRH) agonists may possess a dir...

2015
Monica Sakai Daniel B. Martinez-Arguelles Nathan H. Patterson Pierre Chaurand Vassilios Papadopoulos

Degarelix is a gonadrotropin-releasing hormone (GnRH) receptor (GnRHR) antagonist used in patients with prostate cancer who need androgen deprivation therapy. GnRHRs have been found in extra-pituitary tissues, including prostate, which may be affected by the GnRH and GnRH analogues used in therapy. The direct effect of degarelix on human prostate cell growth was evaluated. Normal prostate myofi...

Journal: :iranian journal of public health 0
dariush. d farhud marjan zarif yeganeh hosein sadighi shahram zandvakili

background: androgen insensitivity syndrome (ais) or testicular feminization is a partial or complete inability of cell response to androgen. the cause is enzymatic defect in synthesis of testosterone, resulting sexually immature phenotypically female, with primary amenorrhea. there are three categories of ais, complete, partial and mild, depending on the degree of external genital masculinizat...

Journal: :Endocrinology 2004
Neil J MacLusky Tibor Hajszan Csaba Leranth

The effects of androgens and the androgen antagonist, flutamide, on the density of dendritic spine synapses in the CA1 subfield of the hippocampus were studied in gonadectomized male and female rats. Treatment of orchidectomized male rats with dehydroepiandrosterone (DHEA; 2 d, 1 mg/d sc) increased the density of CA1 spine synapses observed 2 d later, by 106%, without significantly affecting ve...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2012
Masahiro Okamoto Yasushi Hojo Koshiro Inoue Takashi Matsui Suguru Kawato Bruce S McEwen Hideaki Soya

Mild exercise activates hippocampal neurons through the glutamatergic pathway and also promotes adult hippocampal neurogenesis (AHN). We hypothesized that such exercise could enhance local androgen synthesis and cause AHN because hippocampal steroid synthesis is facilitated by activated neurons via N-methyl-D-aspartate receptors. Here we addressed this question using a mild-intense treadmill ru...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید